Getinge AB (CHIX:GETIBS) Cyclically Adjusted Revenue per Share: kr113.54 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:GETIBS Getinge AB CHIX:GETIBS
73 GF Score
Price kr231.00
GF Value kr192.70
Valuation Modestly Overvalued
! 10 Warning Signs
View Full Analysis

What is Getinge AB Cyclically Adjusted Revenue per Share?

Getinge AB CHIX:GETIBS 73 Cyclically Adjusted Revenue per Share is kr113.54 as of Jun. 2026. GuruFocus rates CHIX:GETIBS with a GF Score™ of 73/100 and a GF Value™ of kr192.70 (Modestly Overvalued). The stock has 10 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Getinge AB's adjusted revenue per share for the three months ended in Jun. 2026 was kr30.771. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr113.54 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Getinge AB's average Cyclically Adjusted Revenue Growth Rate was -2.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 0.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 3.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Getinge AB was 6.20% per year. The lowest was 0.30% per year. And the median was 3.55% per year.

As of today (2026-07-27), Getinge AB's current stock price is kr231.00. Getinge AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was kr113.54. Getinge AB's Cyclically Adjusted PS Ratio of today is 2.03.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Getinge AB was 3.94. The lowest was 0.77. And the median was 1.67.


Getinge AB  (CHIX:GETIBs) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Getinge AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=231.00/113.54
=2.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Getinge AB was 3.94. The lowest was 0.77. And the median was 1.67.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Getinge AB Cyclically Adjusted Revenue per Share Related Terms


Getinge AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Getinge AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Getinge AB Cyclically Adjusted Revenue per Share Chart

Getinge AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 107.60 118.97 122.38 121.73 118.45

Getinge AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 120.42 121.98 118.45 120.55 113.54

CHIX:GETIBS vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Getinge AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Getinge AB Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Getinge AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Getinge AB's Cyclically Adjusted PS Ratio falls into.


CHIX:GETIBS
73GF Score
Getinge AB CHIX:GETIBS
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Getinge AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Getinge AB's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=30.771/134.1100*134.1100
=30.771

Current CPI (Jun. 2026) = 134.1100.

Getinge AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 28.658 101.138 38.001
201612 8.011 102.022 10.531
201703 19.898 102.022 26.156
201706 22.206 102.752 28.983
201709 20.020 103.279 25.996
201712 27.062 103.793 34.967
201803 17.873 103.962 23.056
201806 21.041 104.875 26.907
201809 20.865 105.679 26.478
201812 28.968 105.912 36.681
201903 20.369 105.886 25.798
201906 23.046 106.742 28.955
201909 22.895 107.214 28.639
201912 31.200 107.766 38.827
202003 22.150 106.563 27.876
202006 25.594 107.498 31.930
202009 29.284 107.635 36.487
202012 32.452 108.296 40.188
202103 22.649 108.360 28.031
202106 24.184 108.928 29.775
202109 23.152 110.338 28.140
202112 29.328 112.486 34.966
202203 22.697 114.825 26.509
202206 24.489 118.384 27.742
202209 25.484 122.296 27.946
202212 31.200 126.365 33.112
202303 26.218 127.042 27.677
202306 26.347 129.407 27.305
202309 27.929 130.224 28.763
202312 36.359 131.912 36.965
202403 27.584 132.205 27.981
202406 30.492 132.716 30.812
202409 28.895 132.304 29.289
202412 40.647 132.987 40.990
202503 30.547 132.825 30.843
202506 30.246 133.699 30.339
202509 30.202 133.480 30.345
202512 37.398 133.390 37.600
202603 27.327 133.560 27.440
202606 30.771 134.110 30.771

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of kr113.54 mean?
Getinge AB (CHIX:GETIBS) has a Cyclically Adjusted Revenue per Share of kr113.54 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Getinge AB and its competitors.
Is Getinge AB's Cyclically Adjusted Revenue per Share too high?
Getinge AB's current Cyclically Adjusted Revenue per Share is kr113.54. Overall, Getinge AB has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Getinge AB's Cyclically Adjusted Revenue per Share compare to ABT and SYK?
Getinge AB's Cyclically Adjusted Revenue per Share of kr113.54 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Getinge AB and its competitors. Getinge AB's current Cyclically Adjusted Revenue per Share is kr113.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Getinge AB stock overvalued right now?
Based on GuruFocus' analysis, Getinge AB (CHIX:GETIBS) is currently considered Modestly Overvalued. The stock's GF Value™ is kr192.70, compared to a current price of kr231.00 — trading 19.9% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is kr113.54. Getinge AB's overall GF Score™ is 73/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Getinge AB (CHIX:GETIBS), the current Cyclically Adjusted Revenue per Share is kr113.54 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Getinge AB (CHIX:GETIBS) Overvalued in 2026?

Based on GuruFocus' analysis, Getinge AB stock appears to be overvalued. The current stock price of kr231.00 is trading 19.9% above its estimated GF Value™ of kr192.70. GuruFocus considers Getinge AB to be Modestly Overvalued.

Key valuation signals for CHIX:GETIBS:

  • Cyclically Adjusted Revenue per Share: kr113.54
  • GF Value™: kr192.70 vs. price of kr231.00 (19.9% above fair value)
  • GF Score™: 73/100 with 10 warning signs

No single metric tells the full story. See the CHIX:GETIBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Getinge AB Business Description

Address Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, 417 56
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (35%), and life sciences (13%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales, Europe, Middle East, and Africa 35%, and Asia-Pacific the remaining 25%.
73GF Score

Get the complete analysis for CHIX:GETIBS

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr231.00
Price
kr192.70
GF Value